Form 4 for ARMP Armata Pharmaceuticals, Inc.
Accepted 2025-04-25 00:00:00 ET · period of report 2025-03-14 · accession 0001104659-25-039414 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-25 | 2025-03-14 | ARMP | Kyme Pierre | Chief Business Off | F - Tax | $1.95 | -1,027 | 10.5K | -9% | -$2,003 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-14 | F | D | 1,027 | $1.95 | 10,491 | D | — | — | (F1) Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units. |